Резултати

eNauka >  Results >  High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study
Title: High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study
Authors: Petzer, A. L.; Wolf, D.; Fong, D.; Lion, T.; Dyagil, I.; Masliak, Z.; Bogdanović, Andrija  ; Griskevicius, L.; Lejniece, S.; Goranov, S.;
Gercheva, L.; Stojanovic, A.; Peytchev, D.; Tzvetkov, N.; Griniute, R.; Oucheva, R.; Ulmer, H.; Kwakkelstein, M.; Rancati, F.; Gastl, G.;
Issue Date: 2010
Publication: Haematologica
ISSN: 0390-6078 Haematologica Search Idenfier
Type: Article
Collation: vol. 95 br. 6 str. 908-913
DOI: 10.3324/haematol.2009.013979
WoS-ID: 000279051100010
Scopus-ID: 2-s2.0-77953208869
PMID: 20145273
PMCID: PMC2878787
URI: https://enauka.gov.rs/handle/123456789/412059
Metadata source: Migrirano iz RIS podataka
M-category: 
21aM21a

23
SCOPUSTM
13
PubMed CentralTM
19
OpenCitations
25
WEB OF SCIENCETM
Алт метрика
Dimensions
Unpaywall

Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.